China Regional Advisory Council
Zili Li
Vice President, Head of Asia Pacific R&D, Janssen Research & Development
-
Feng Chen
Professor, Dean, School of Public Health, Nanjing Medical University
-
Xiaoyuan Chen
Director, GCP Officer, Beijing Tsinghua Changgung Hospital
-
Zhaohua Chen
Head of Global Climical Data Services, Pfizer China R&D Center
-
Haidong Chi
CM0, Lilly China
-
Connie Dai
Vice President, Strategy Innovation and Decision Science, HLT
-
Irene Deng
Head of Regulatory Affairs, China, Sanofi
-
Jianing Di
Senior Director, China Compound Team Leader, Janssen China R&D
-
Kai Gao
Professor, Life Science School, Shanghai University
-
John Gong
CEO, 3DMed
-
Tong Guo
CEO, GEM Flower Pharma Tech
-
Jing He
SVP, Head of China R&D Global Oncology R&D, Astrazeneca
-
Jinjie Hu
Co-Chair of FDAAA International Network Committee, Senior Consultant, Biologics Consulting Group
-
Amy Jiang
Head of Quality Office, Harbour Biomed
-
Michael Jiang
Head of Scientific Relations and Innovation & Business Development, Sanofi
-
Michael Lee
Vice President, Head of Biometrics, Harbour BioMed
-
Vera Liang
Director and Global Safety Risk Lead, Safety Surveillance and Risk Management, Pfizer (China) R&D Co., Ltd.
-
Howe Li
Chairman and CEO, Deltamed Co. Ltd
-
Jintong Li
Deputy Director of Drug Clinical Trial and Research Center, China-Japan Hospital
-
Mengjuan Li
HR Head, Asia Pacific R&D and Innovation, Johnson & Johnson
-
Ning Li
Chief Physician, Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences
-
Shuting Li
Deputy Director, GCP Alliance, China
-
Daniel Liu
Chief Science Officer, Beijing Clinical Service Center
-
Jessica Liu
Vice President, Head of International Business, Tigermed Consulting Co., Ltd
-
Yanfei Liu
Director of GCP, Fudan University Shanghai Cancer Center
-
Yi Liu
Head of Clinical Science and Medical Affairs, dMed Biopharmaceutical Co., Ltd
-
Yuwen Liu
Founding Partner, Bohe Angel Fund
-
Qi Lu
Director, Ethics Committee Office, Renji Hospital affiliated with Shanghai Jiaotong University School of Medicine
-
Shun Lu
Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest Hospital, Shanghai Jiaotong University
-
Yuan Meng
Head of Medical Office R&D, I-Mab Biopharma
-
Reako Ren
Head of SMO Services, WuXi AppTec
-
Gary Wang
VP, Human Resources, APAC, & Co-Lead Global HR, BeiGene
-
Jin Wang
Partner, McKinsey & Company
-
Lin Wang
VP, Leader of Asia Development Center, Takeda
-
Liqun Wang
CEO, FosunKite
-
Xingli Wang
Senior Global Program Clinical Head, Global Drug Development , Novartis China
-
Zaiqi Wang
CEO, InxMed
-
Amy Wu
HR Leader, MSD China R&D
-
Ning Xu
Executive Vice President, Head of Clinical Development and Regulatory Affairs, Zai Lab
-
Angela Yan
Senior Vice President, Regulatory Affairs & Strategy, dMed
-
Charles Yan
Senior Director, Data Management and Biometric, Shanghai Hengrui Medicine Co, LTD
-
Dina Yang
Deputy Director, Head of Communications, China Office, Bill & Melinda Gates Foundation
-
Joanna Yang
Director, Market Access & Pricing Strategy, AstraZeneca China
-
Wendy Yan
Senior Vice President, Head of Regulatory Affairs, BeiGene (Beijing) Co., Ltd.
-
Ping Zhao
General Manager, Greater China, Cstone
-
Liping Zhou
Asia Pacific Quality Assurance Director, MSD
-
Carol Zhu
Vice President, Portfolio and Project Management, JW Therapeutics